Supreme Cannabis (OTCMKTS:SPRWF) Rating Lowered to Hold at Eight Capital

Eight Capital downgraded shares of Supreme Cannabis (OTCMKTS:SPRWF) to a hold rating in a report published on Tuesday morning, TipRanks reports.

Several other equities research analysts have also issued reports on SPRWF. CIBC lowered their price target on shares of Supreme Cannabis from $0.50 to $0.35 and set a neutral rating on the stock in a research note on Tuesday. Stifel Nicolaus decreased their price objective on shares of Supreme Cannabis from $0.50 to $0.30 and set a hold rating for the company in a research report on Tuesday.

Shares of SPRWF stock opened at $0.21 on Tuesday. Supreme Cannabis has a 1 year low of $0.10 and a 1 year high of $1.41. The firm’s fifty day moving average price is $0.20 and its two-hundred day moving average price is $0.34.

About Supreme Cannabis

The Supreme Cannabis Company, Inc engages in the production of medical cannabis in Canada. The company was formerly known as Supreme Pharmaceuticals Inc and changed its name to The Supreme Cannabis Company, Inc in December 2017. The Supreme Cannabis Company, Inc was incorporated in 1979 and is headquartered in Toronto, Canada.

Featured Article: Intrinsic Value and Stock Selection

Receive News & Ratings for Supreme Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Supreme Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.